Turn Biotechnologies acquires ARMMs vesicular technology to increase access to tissue targets for its ERA™ epigenetic reprogramming therapies Learn More

 

Turn Biotechnologies is pioneering epigenetic reprogramming technologies that enable cells to fight disease or repair damaged tissue. We develop mRNA cocktails to restore cell function that is often lost with age at the genome level, and transport those therapies to targeted tissues or organs using proprietary, cutting-edge delivery technologies.


 
 
 
AdobeStock_222958906.jpg

Our science is the latest step in cellular programming.

 
 
 
AdobeStock_256825367_edit-01.png